Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glycerate kinase (GLYCTK) is a cytoplasmic and mitochondrial enzyme that facilitates the phosphorylation of (R)-glycerate to 3-phosphoglycerate, a crucial step in several cellular metabolic processes including amino acid and lipid metabolism. Mutations disrupting GLYCTK’s activity cause D-glyceric aciduria, a rare autosomal recessive disorder marked by neurological deficits and developmental delay due to accumulation of D-glyceric acid. The enzyme is essential for proper energy metabolism, with clinical importance in genetic diagnostics rather than as a drug target.
Not applicable (no known drugs targeting this enzyme); mutation causes loss of enzyme function
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycerate kinase (GLYCTK).